Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Nilotinib | 0.31623 | uM | 5 | 312.50 | 138.75 | 338.00 | 242.00 | 1.3967 | 2.0328 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 5 | 312.50 | 138.75 | 167.00 | 242.00 | 0.6901 | 0.2598 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 5 | 312.50 | 138.75 | 361.00 | 242.00 | 1.4917 | 2.2920 |
| SK-BR-3 | PLX-4720 | 1 | uM | 5 | 312.50 | 138.75 | 213.00 | 242.00 | 0.8802 | 0.7059 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 5 | 312.50 | 138.75 | 223.00 | 242.00 | 0.9215 | 0.8063 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 227.00 | 242.00 | 0.9380 | 0.8467 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 173.00 | 242.00 | 0.7149 | 0.3164 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 188.00 | 242.00 | 0.7769 | 0.4601 | |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 205.00 | 242.00 | 0.8471 | 0.6264 | |
| SK-BR-3 | Etoposide | 0.01 | uM | 5 | 312.50 | 138.75 | 213.00 | 242.00 | 0.8802 | 0.7059 |
| SK-BR-3 | Etoposide | 0.31623 | uM | 5 | 312.50 | 138.75 | 276.00 | 242.00 | 1.1405 | 1.3560 |
| SK-BR-3 | PLX-4720 | 0.1 | uM | 5 | 312.50 | 138.75 | 292.00 | 242.00 | 1.2066 | 1.5274 |
| SK-BR-3 | Nilotinib | 0.01 | uM | 5 | 312.50 | 138.75 | 238.00 | 242.00 | 0.9835 | 0.9589 |
| SK-BR-3 | Nilotinib | 0.1 | uM | 5 | 312.50 | 138.75 | 315.00 | 242.00 | 1.3017 | 1.7778 |
| SK-BR-3 | Etoposide | 19.9526 | uM | 5 | 312.50 | 138.75 | 140.00 | 242.00 | 0.5785 | 0.0112 |
| SK-BR-3 | PLX-4720 | 0.01 | uM | 5 | 312.50 | 138.75 | 285.00 | 242.00 | 1.1777 | 1.4521 |
| SK-BR-3 | PLX-4720 | 3.1623 | uM | 5 | 312.50 | 138.75 | 263.00 | 242.00 | 1.0868 | 1.2185 |
| SK-BR-3 | Nilotinib | 10 | uM | 5 | 312.50 | 138.75 | 724.00 | 242.00 | 2.9917 | 6.8355 |
| SK-BR-3 | NVP-TAE684 | 0.0016596 | uM | 5 | 312.50 | 138.75 | 201.00 | 242.00 | 0.8306 | 0.5870 |
| SK-BR-3 | Nilotinib | 1 | uM | 5 | 312.50 | 138.75 | 327.00 | 242.00 | 1.3512 | 1.9103 |
| SK-BR-3 | NVP-TAE684 | 0.1 | uM | 5 | 312.50 | 138.75 | 298.00 | 242.00 | 1.2314 | 1.5922 |
| SK-BR-3 | PLX-4720 | 10 | uM | 5 | 312.50 | 138.75 | 259.00 | 242.00 | 1.0702 | 1.1766 |
| SK-BR-3 | Nilotinib | 19.9526 | uM | 5 | 312.50 | 138.75 | 798.00 | 242.00 | 3.2975 | 7.8457 |
| SK-BR-3 | 0 | uM | 5 | 312.50 | 138.75 | 331.00 | 242.00 | 1.3678 | 1.9547 | |
| SK-BR-3 | NVP-TAE684 | 3.1623 | uM | 5 | 312.50 | 138.75 | 200.00 | 242.00 | 0.8265 | 0.5772 |